NEW YORK (GenomeWeb) – Danaher today reported that revenues in its second quarter grew almost 4 percent year over year with growth in its Life Sciences and Diagnostics segment a little less than 3 percent. 

For the three months ended July 3, the Washington-based conglomerate posted total revenues of $5.13 billion, up from $4.96 billion in the year-ago quarter, and above the consensus Wall Street estimate of $5.06 billion. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.